Algert Global’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-280,882
| Closed | -$935K | – | 1251 |
|
|
2025
Q1 | $935K | Buy |
280,882
+224,482
| +398% | +$747K | 0.02% | 779 |
|
|
2024
Q4 | $417K | Buy |
56,400
+2,330
| +4% | +$17.2K | 0.01% | 943 |
|
|
2024
Q3 | $508K | Buy |
54,070
+18,784
| +53% | +$176K | 0.01% | 893 |
|
|
2024
Q2 | $283K | Sell |
35,286
-3,492
| -9% | -$28K | 0.01% | 1143 |
|
|
2024
Q1 | $575K | Sell |
38,778
-81,310
| -68% | -$1.21M | 0.02% | 745 |
|
|
2023
Q4 | $976K | Sell |
120,088
-273,688
| -70% | -$2.22M | 0.04% | 625 |
|
|
2023
Q3 | $1.79M | Buy |
393,776
+41,470
| +12% | +$189K | 0.08% | 396 |
|
|
2023
Q2 | $2.48M | Sell |
352,306
-62,707
| -15% | -$441K | 0.11% | 326 |
|
|
2023
Q1 | $2.54M | Buy |
415,013
+23,620
| +6% | +$144K | 0.12% | 266 |
|
|
2022
Q4 | $2.5M | Buy |
391,393
+47,720
| +14% | +$305K | 0.14% | 225 |
|
|
2022
Q3 | $3.29M | Buy |
343,673
+178,868
| +109% | +$1.71M | 0.2% | 128 |
|
|
2022
Q2 | $1.82M | Buy |
164,805
+117,027
| +245% | +$1.29M | 0.14% | 222 |
|
|
2022
Q1 | $796K | Buy |
47,778
+11,403
| +31% | +$190K | 0.05% | 617 |
|
|
2021
Q4 | $694K | Buy |
36,375
+2,537
| +7% | +$48.4K | 0.09% | 415 |
|
|
2021
Q3 | $834K | Buy |
33,838
+20,388
| +152% | +$503K | 0.11% | 322 |
|
|
2021
Q2 | $350K | Buy |
+13,450
| New | +$350K | 0.12% | 248 |
|
|
2021
Q1 | – | Sell |
-11,621
| Closed | -$539K | – | 479 |
|
|
2020
Q4 | $539K | Buy |
+11,621
| New | +$539K | 0.15% | 213 |
|
|
2020
Q3 | – | Sell |
-30,757
| Closed | -$844K | – | 444 |
|
|
2020
Q2 | $844K | Sell |
30,757
-19,392
| -39% | -$532K | 0.29% | 125 |
|
|
2020
Q1 | $1.5M | Buy |
50,149
+26,138
| +109% | +$782K | 0.63% | 24 |
|
|
2019
Q4 | $665K | Buy |
+24,011
| New | +$665K | 0.2% | 170 |
|
|
2019
Q3 | – | Sell |
-13,080
| Closed | -$321K | – | 398 |
|
|
2019
Q2 | $321K | Buy |
+13,080
| New | +$321K | 0.12% | 215 |
|